Compare CNX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNX | MIR |
|---|---|---|
| Founded | 1860 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Oil & Gas Production | Industrial Machinery/Components |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.6B |
| IPO Year | 1998 | N/A |
| Metric | CNX | MIR |
|---|---|---|
| Price | $36.04 | $15.73 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $35.71 | $27.25 |
| AVG Volume (30 Days) | 1.7M | ★ 4.0M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 763.33 | N/A |
| EPS | ★ 3.56 | N/A |
| Revenue | ★ $2,239,134,000.00 | N/A |
| Revenue This Year | N/A | $23.95 |
| Revenue Next Year | $11.14 | $7.32 |
| P/E Ratio | ★ $10.06 | $195.00 |
| Revenue Growth | ★ 76.76 | N/A |
| 52 Week Low | $27.72 | $14.11 |
| 52 Week High | $43.62 | $30.28 |
| Indicator | CNX | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 39.01 |
| Support Level | $35.59 | N/A |
| Resistance Level | $37.67 | $20.29 |
| Average True Range (ATR) | 0.99 | 0.81 |
| MACD | 0.30 | -0.11 |
| Stochastic Oscillator | 93.89 | 30.25 |
CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.